News

Empowering Cardiovascular Programs through APP Leadership and Insights

Empowering Cardiovascular Programs through APP Leadership and Insights

Revolutionizing Cardiovascular Care with Advanced Practice Providers

In today's fast-evolving healthcare landscape, Advanced Practice Providers (APPs) are playing an increasingly vital role in the success of cardiovascular programs. MedAxiom, a notable leader in cardiovascular organizational performance solutions, has recently released its 2024 Cardiovascular Advanced Practice Provider (APP) Compensation and Utilization Report. This extensive report, which draws from insights gathered across 90 provider organizations, sheds light on the trends and developments shaping the role of APPs within the field of cardiovascular care.

Key Findings of the APP Compensation and Utilization Report

The report provides illuminating insights into the changing dynamics of APP compensation and utilization in cardiovascular settings. One standout finding is the continued increase in median compensation for cardiology APPs. Over the course of four years, from 2019 to 2023, there has been a noteworthy 15% growth in average compensation, highlighting the increasing value and demand for these skilled providers.

APP Leadership and Team Structure

Another significant aspect revealed in the report is the structure of APP teams. Almost half of the programs surveyed reported that an APP is in a leadership role within their respective teams. This trend signifies the importance of APP leadership in enhancing program success, as these providers bring a unique perspective and skill set that contributes to better care delivery.

APP Engagement in Ambulatory Settings

Furthermore, the report reveals that over 90% of APPs are now actively working in ambulatory settings, a substantial increase from 80% previously. This shift underscores the growing reliance on APPs to provide care outside traditional hospital settings, which can result in greater access to services for patients.

Adopting Team-Based Care Models

The implementation of team-based care models continues to benefit specialty care practices. According to the report, 62% of programs have deployed APPs specifically for lipid management and preventive care. This trend is crucial as it indicates a strategic move towards improving overall patient outcomes through specialized care.

The Importance of Staff Retention

As highlighted by the executive vice president of MedAxiom Care Transformation Services, Ginger Biesbrock, the establishment of thoughtfully designed team-based care models can help alleviate workflow challenges. By fostering a flexible workplace culture, these models enhance the ability to deliver subspecialized care effectively. However, as the demand for APPs grows, retaining these skilled professionals is essential for long-term success. The report outlines various strategies to retain and motivate APPs, which is crucial for sustaining high-quality cardiovascular care.

Addressing Workforce Challenges

The 2024 report serves as a foundational resource, addressing several challenges faced by APPs in cardiovascular care. It includes discussions on the complications arising from subspecialization, expanding patient populations, and ongoing workforce shortages. Additionally, there is a dedicated section focusing on the enhanced responsibilities of APPs in preventive measures and lipid management programs, an area that has gained considerable traction.

Accessing Comprehensive Insights

For those wishing to delve deeper into these findings, the complete report can be accessed through MedAxiom's platform. This comprehensive document not only outlines compensation trends but also presents actionable insights to help medical organizations shape effective care models.

About MedAxiom

MedAxiom, affiliated with the American College of Cardiology, stands as a beacon for cardiovascular excellence, providing vital solutions for organizational performance. By harnessing the collective expertise of numerous cardiovascular organizations, MedAxiom is at the forefront of transforming cardiovascular care. Through their innovative tools and data-driven strategies, they aim to achieve the Quadruple Aim: better outcomes, lower costs, an improved patient experience, and enhanced clinician satisfaction. For further insights and resources, More information can be found at MedAxiom's official site.

Frequently Asked Questions

What is the main focus of the 2024 MedAxiom report?

The report centers on the compensation and utilization trends of Advanced Practice Providers in cardiovascular care, based on data from various organizations.

How has APP compensation changed over the years?

Median compensation for cardiology APPs has increased by 15% from 2019 to 2023, reflecting a growing appreciation for their roles.

What percentage of APPs work in ambulatory settings?

The report states that more than 90% of APPs are engaged in ambulatory care, which is an increase from 80% in the previous year.

Why is APP leadership important in cardiovascular programs?

APP leadership is crucial as it drives team success and ensures effective care delivery, with nearly half of the surveyed programs having an APP in a leadership role.

What are the benefits of team-based care models?

Team-based care models with APPs lead to improved workflow, flexibility, and better patient outcomes, particularly in specialized areas like lipid management.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Windward Bio Surges 68% in Nasdaq Debut

Updated Category News Views 243

Windward Bio's Impressive Nasdaq Debut Well, how's that for a debut? Windward Bio, this buzzing clinical-stage biotechnology firm, hit Nasdaq like a storm on November 13, 2026. They priced their IPO at $17.00 per share, but by market close, the stock sat comfortably at $28.50. That's a hearty 68% jump on day one, putting their market value at a sweet $1.69 billion. Behind...

Continue Reading
Retirement Dreams Dashed: 61% Withdraw Early

Updated Category News Views 183

Retirement Caught in the Crosshairs Just when you think the path to retirement might clear up, life slaps down older workers with economic reality. A recent LiveCareer survey underscores this financial mess, revealing that 61% of those 50 and older are raiding their own retirement funds to make ends meet. It's enough to make one's head spin. Inflation: The Unwanted Guest...

Continue Reading
SmallRig Boosts Art-Driven Innovation in AI Era

Updated Category News Views 148

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Continue Reading
HONGQI's EHS4 Launch in Europe: Bridging East and West

Updated Category News Views 105

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Continue Reading
Greenberg Traurig's Brad Kaufman: A Mentor of Resolute Impact

Updated Category News Views 315

A Milestone for Mentorship at Greenberg Traurig In the often cutthroat jungle of law, finding someone who actually gives a damn about you is as rare as finding a unicorn. Yet, there it is—Brad Kaufman, at the helm of Greenberg Traurig's professional development, proving that mentorship can be more than just a checkbox on a quarterly review. Award for Exceptional...

Continue Reading
BETR's Slide: Investors Face Big Losses, Leadership Shift

Updated Category News Views 113

BETR Investors Left in the Lurch It's a real trainwreck, folks. Better Home & Finance Holding Company, trading under NASDAQ:BETR, is in the spotlight for all the wrong reasons. The company expanded the class period for its investor lawsuit to include even more dates between March and August 2026, reflecting a torturous ride for shareholders. Their stock cratered by a...

Continue Reading
El Pollo Loco Faces Class Action Over Wage Practices

Updated Category News Views 234

Alright, here's where things start sizzling—El Pollo Loco, the fast-food chicken chain whose name translates to 'The Crazy Chicken'—is in a legal pickle. The lawsuit hanging over their heads could spell a sticky situation for them and possibly ripple through the fast-food industry. The suit, filed by the steadfast firm Blumenthal Nordrehaug Bhowmik De Blouw LLP, has...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 244

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 108

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 223

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading

Top 5 Most Recently Viewed Articles

WTW's Strategic Acquisitions: A Leap into the Future of Insurance

Updated Category News Views 178

WTW Expands Through Innovative Acquisitions Willis Towers Watson Public Ltd., known as WTW, is making headlines with its ambitious strategy to enhance its technology-enabled insurance and workplace benefits services. By announcing two consequential acquisitions, WTW aims to broaden its reach in the middle market while modernizing its client interactions significantly....

Continue Reading
Microsoft Faces Competition After Downgrade from D.A. Davidson

Updated Category News Views 120

Microsoft's Recent Downgrade by Analysts Analysts at D.A. Davidson have made headlines by downgrading Microsoft's (NASDAQ: MSFT) rating from Buy to Neutral. They have kept a price target of $475, reflecting ongoing evaluations of Microsoft's market strategies and performance. Factors Contributing to the Downgrade A key reason for this downgrade is the increasing...

Continue Reading
Portman Ridge Finance Faces Market Challenges with PTMN Stock

Updated Category News Views 133

Portman Ridge Finance Corporation Stock Overview In the current economic landscape, Portman Ridge Finance Corporation (NASDAQ: PTMN) has seen its stock touch a 52-week low, now priced at $16.19. This significant drop highlights a shift in investor sentiment, with key indicators such as the Relative Strength Index (RSI) signaling that the stock may be oversold. Notably,...

Continue Reading
Miami International Holdings Sees Growth in July Trading

Updated Category News Views 135

Miami International Holdings Reports Trading Results Miami International Holdings, Inc., a technology-driven leader in financial markets, has announced significant trading results for July 2025. The company operates several exchanges, including MIAX, MIAX Pearl, MIAX Emerald, MIAX Sapphire, and MIAX Futures. These results demonstrate a capacity for growth and stability in...

Continue Reading
Intel's Game-Changing Innovations at CES 2025 Unveiled

Updated Category News Views 220

Unveiling Innovations at CES 2025 At a highly anticipated event in Las Vegas, Intel took the stage at CES 2025 to reveal its latest technological advancements in mobile computing and edge solutions. With the launch of the new Intel Core Ultra (Series 2) processors, Intel is set to lead the charge in revolutionizing the way businesses, creators, and gaming enthusiasts...

Continue Reading